Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma

Mostrar otras versiones (1)

The absolute peripheral blood lymphocyte count at diagnosis is known to be a strong prognostic factor in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), but it remains unclear as to which peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusano, Y, Yokoyama, M, Terui, Y, Nishimura, N, Mishima, Y, Ueda, K, Tsuyama, N, Hirofumi, Y, Takahashi, A, Inoue, N, Takeuchi, K, Hatake, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436080/
https://www.ncbi.nlm.nih.gov/pubmed/28430176
http://dx.doi.org/10.1038/bcj.2017.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436080/
https://www.ncbi.nlm.nih.gov/pubmed/28430176
http://dx.doi.org/10.1038/bcj.2017.37

Ejemplares similares